Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...
Brain-computer interface (BCI) specialist Synchron has previewed an artificial intelligence model that it believes will form the basis of a new generation of devices to allow individuals to control ...
Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback